Andrew Rae Rae

Andrew Rae Rae discloses dealings in iCo Therapeutics Inc. to SEDI. The record holds 11 filings, for trades running from 20 January 2016 to 23 May 2018.

No open-market sale appears; the market trades are 11 purchases worth €58k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2018: 3 purchases and no sales on the market.

In size, the median ticket on the buying side is €3,987. The 11 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The record was last updated on 23 May 2018 with an open-market purchase (€10k) in iCo Therapeutics Inc. Filings reach the SEDI feed a median of 1 day after the trade. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.